INNOVATIVE EYEWEAR, INC. Deferred Revenue
INNOVATIVE EYEWEAR, INC. (LUCY) had Deferred Revenue of $19.87 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-14
- 2026-06-30: Deferred Revenue, Current $19.87K.
- 2026-03-31: Deferred Revenue, Current $14.97K.
- 2025-12-31: Deferred Revenue, Current $59.89K.
- 2025-09-30: Deferred Revenue, Current $48.59K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2026-06-30 | $19.87K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $14.97K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $59.89K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $48.59K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $68.30K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $81.84K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $44.90K 10-K · filed 2026-03-25 |
| 2024-09-30 | $45.01K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $42.50K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $42.50K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $42.50K 10-K · filed 2025-03-24 |
| 2023-09-30 | $42.95K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $30.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $30.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $30.00K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |